StockData

Canopy Growth vs SNDL

CGC and SNDL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CGC and SNDL compare

Canopy Growth grew revenue faster over the last twelve months (6.8% versus 2.8% for SNDL).

SNDL keeps more of each dollar of sales as profit, with a net margin of −1.7% compared with −79.2% at Canopy Growth.

SNDL scores higher on the StockData Score (5 against 3 for Canopy Growth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCGCSNDL
Size and price
Share price$0.531$1.34
Change, 1 year−50.3%−20.2%
Change, 5 years−99.5%−79.5%
Beta (5Y)1.230.39
Employees1,1282,607
StockData Score
Total score35 (better)
Valuation score00
Growth score11
Performance score13 (better)
Health score11
Dividend score00
Growth
Revenue growth (TTM)6.8% (better)2.8%
Revenue growth, 5Y average−12.2%73.1% (better)
Profitability
Gross margin25.2%27.3% (better)
Operating margin−54.9%−0.67% (better)
Net margin−79.2%−1.7% (better)
FCF margin−28.3%6.1% (better)
Return on equity–−1.4%
Return on invested capital–−0.57%
Financial health
Interest coverage−3.9×−0.9× (better)
Current ratio3.044.88 (better)
Piotroski F-score57 (better)
Ownership
Held by institutions6.9%18.6%
Held by insiders1.0%0.00%
Insider net buying, 12 months−$393K–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.